Revolution Medicines (RVMD) Free Cash Flow (2019 - 2026)
Revolution Medicines (RVMD) posted Free Cash Flow of -$389.6 million for Q2 2026, down 9.53% on a QoQ basis from -$355.7 million in Q1 2026, and down 69.98% year-over-year from -$1.3 billion in Q2 2025.
Powered by 
Analysis
Revolution Medicines (RVMD) Free Cash Flow (2019 - 2026) Analysis & Trends
Revolution Medicines has reported Free Cash Flow for 8 years, with the latest figure at -$389.6 million in Q2 2026.
- On a quarterly basis, Free Cash Flow fell 69.98% year-over-year to -$389.6 million in Q2 2026; TTM through Jun 2026 was -$1.2 billion, a 75.93% decrease from a year earlier, with the FY2025 full-year figure at -$913.7 million, down 60.94% from the prior year.
- Free Cash Flow was -$389.6 million for Q2 2026 at Revolution Medicines, down from -$355.7 million in the prior quarter.
- The five-year high for Free Cash Flow was -$55.3 million in Q3 2022, with the low at -$389.6 million in Q2 2026.
- Average Free Cash Flow over 5 years is -$156.7 million, with a median of -$132.3 million recorded in 2024.
- The sharpest annual moves came in 2023 and 2024: Free Cash Flow slipped 12.45% in 2023, then slumped 155.23% in 2024.
- Over 5 years, Free Cash Flow stood at -$64.7 million in 2022, then tumbled by 85.26% to -$119.8 million in 2023, then dropped by 16.46% to -$139.5 million in 2024, then tumbled by 97.95% to -$276.2 million in 2025, then plunged by 41.08% to -$389.6 million in 2026.
- The last three Free Cash Flow figures came in at -$389.6 million (Q2 2026), -$355.7 million (Q1 2026), and -$276.2 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.01 Bn | 628.25 Bn | 17.26 Bn | 7.30 Bn |
| 2 | AbbVie | 468.55 Bn | 462.03 Bn | 12.70 Bn | 3.11 Bn |
| 3 | Merck | 365.49 Bn | 358.40 Bn | 12.21 Bn | 4.48 Bn |
| 4 | Novartis Ag | 272.39 Bn | 265.10 Bn | 11.24 Bn | 6.20 Bn |
| 5 | Astrazeneca | 253.18 Bn | 247.96 Bn | 12.86 Bn | 3.63 Bn |
| 6 | Amgen | 219.53 Bn | 205.54 Bn | 7.24 Bn | 3.49 Bn |
| 7 | Gilead Sciences | 187.85 Bn | 184.59 Bn | 6.22 Bn | 3.43 Bn |
| 8 | Pfizer | 160.56 Bn | 149.16 Bn | 10.94 Bn | 302.00 Mn |
| 9 | Vertex Pharmaceuticals | 130.81 Bn | 122.96 Bn | 2.84 Bn | 1.01 Bn |
| 10 | Revolution Medicines | 40.86 Bn | 40.86 Bn | - | -389.61 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -389.61 Mn |
| Mar 31, 2026 | -355.70 Mn |
| Dec 31, 2025 | -276.16 Mn |
| Sep 30, 2025 | -210.66 Mn |
| Jun 30, 2025 | -229.21 Mn |
| Mar 31, 2025 | -197.70 Mn |
| Dec 31, 2024 | -139.51 Mn |
| Sep 30, 2024 | -133.94 Mn |
| Jun 30, 2024 | -130.57 Mn |
| Mar 31, 2024 | -163.73 Mn |
| Dec 31, 2023 | -119.80 Mn |
| Sep 30, 2023 | -106.12 Mn |
| Jun 30, 2023 | -68.24 Mn |
| Mar 31, 2023 | -64.15 Mn |
| Dec 31, 2022 | -64.66 Mn |
| Sep 30, 2022 | -55.26 Mn |
| Jun 30, 2022 | -58.24 Mn |
| Mar 31, 2022 | -57.05 Mn |
| Dec 31, 2021 | -40.45 Mn |
| Sep 30, 2021 | -37.04 Mn |
API Access
Revolution Medicines Free Cash Flow API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=free-cash-flow&ticker=RVMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "free-cash-flow", "ticker": "RVMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=free-cash-flow&ticker=RVMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();